Literature DB >> 3040219

The histologic response of soft tissue sarcoma to radiation therapy.

C G Willett, A L Schiller, H D Suit, H J Mankin, A Rosenberg.   

Abstract

Twenty-seven patients with soft tissue sarcoma had preoperative radiotherapy, limb-sparing marginal surgical resection and whole-mount tumor histologic analysis. Incisional biopsy specimens before radiotherapy were reviewed for tumor type, grade, and extent of necrosis. Preoperative radiotherapy was given in either of two regimens: 13 patients received a mean total dose of 5250 cGy in one daily 180 to 200 cGy fractions and 14 patients a mean total dose of 4770 cGy in two daily fractions of 180 to 200 cGy separated by 4 hours. Twenty-one specimens had at least 80% necrosis or severely altered cells, a 3+ to 4+ response. Grade and size of the tumor appeared to be indicators of response to treatment rather than histologic type. Three of five patients (60%) with Grade 1, eight of 11 patients (73%) with Grade 2 lesions, and ten of 11 patients (91%) with Grade 3 tumors had 80% or greater necrosis or severely altered cells. For tumors 10 cm or less in greatest diameter, the 3+ to 4+ histologic response was seen in 12 of 14 patients (86%) whereas for lesions greater than 10 cm, this response was observed in nine of 13 patients (69%). For patients with Grade 2 or 3 soft tissue sarcoma, 13 of 14 patients (93%) treated with two fractions per day and two of four patients (50%) receiving one fraction per day exhibited significant response. All six patients treated twice daily for lesions greater than 10 cm had 3+ to 4+ histologic response compared to three of seven (43%) patients treated once per day. Therefore, grade and size of soft tissue sarcoma are important predictors of response to radiotherapy and preoperative twice daily radiotherapy may more likely permit the conservative surgical excision of sarcomas of borderline resectability.

Entities:  

Mesh:

Year:  1987        PMID: 3040219     DOI: 10.1002/1097-0142(19871001)60:7<1500::aid-cncr2820600716>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma.

Authors:  Dhruvil Shah; Dariusz Borys; Steve R Martinez; Chin-Shang Li; Robert M Tamurian; Richard J Bold; Arta Monjazeb; Robert J Canter
Journal:  Anticancer Res       Date:  2012-09       Impact factor: 2.480

Review 2.  Molecular Predictors of Radiotherapy Response in Sarcoma.

Authors:  Carlos H F Chan; Philip Wong
Journal:  Curr Treat Options Oncol       Date:  2016-01

Review 3.  Liposarcoma: a soft tissue tumor with many presentations.

Authors:  H J Mankin; K P Mankin; D C Harmon
Journal:  Musculoskelet Surg       Date:  2014-07-22

4.  Human Endothelial Colony Forming Cells Express Intracellular CD133 that Modulates their Vasculogenic Properties.

Authors:  Elisa Rossi; Sonia Poirault-Chassac; Ivan Bieche; Richard Chocron; Anne Schnitzler; Anna Lokajczyk; Pierre Bourdoncle; Blandine Dizier; Nour C Bacha; Nicolas Gendron; Adeline Blandinieres; Coralie L Guerin; Pascale Gaussem; David M Smadja
Journal:  Stem Cell Rev Rep       Date:  2019-08       Impact factor: 5.739

5.  A non-comparative phase II study of dose intensive chemotherapy with doxorubicin and ifosfamide followed by high dose ICE consolidation with PBSCT in non-resectable, high grade, adult type soft tissue sarcomas.

Authors:  Jörg Thomas Hartmann; M Horger; T Kluba; A Königsrainer; P de Zwart; C Hann von Weyhern; F Eckert; W Budach; C Bokemeyer
Journal:  Invest New Drugs       Date:  2013-10-04       Impact factor: 3.850

6.  Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcoma.

Authors:  Robert J Canter; Steve R Martinez; Robert M Tamurian; Maaya Wilton; Chin-Shang Li; Janice Ryu; Walter Mak; Wayne L Monsky; Dariusz Borys
Journal:  Ann Surg Oncol       Date:  2010-06-17       Impact factor: 5.344

7.  Comparison of charges related to radiotherapy for soft-tissue sarcomas treated by preoperative external-beam irradiation versus interstitial implantation.

Authors:  N A Janjan; A W Yasko; G P Reece; M J Miller; J A Murray; M I Ross; M M Romsdahl; M J Oswald; T G Ochran; R E Pollock
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

Review 8.  [Radiotherapy of soft tissue sarcoma--part of a multidisciplinary strategy].

Authors:  Hildegard Pape; Klaus Orth; Rainer Engers; Christiane Matuschek; Anja Müller; Karl-Axel Hartmann; Peter Arne Gerber; Guido Lammering; Daniel Habermehl; Roland Fenk; Wilfried Budach; Stephan Gripp; Matthias Peiper; Edwin Bölke
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

9.  High incidence of metastatic disease in primary high grade and large extremity soft tissue sarcomas treated without chemotherapy.

Authors:  Benedikt Leidinger; Thomas Heyse; Andreas Schuck; Horst Buerger; Philipp Mommsen; Thomas Bruening; Susanne Fuchs; Georg Gosheger
Journal:  BMC Cancer       Date:  2006-06-18       Impact factor: 4.430

10.  The radiation response of sarcomas by histologic subtypes: a review with special emphasis given to results achieved with razoxane.

Authors:  Walter Rhomberg
Journal:  Sarcoma       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.